Trial intelligence / Profile preview

Dexmedetomidine and Flurbiprofen for Postoperative Sore Throat After Thyroidectomy

ChiCTR2100044376Phase 4Recruiting

Sponsor
First Affiliated Hospital of Anhui Medical University
Start
Mar 2021
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine and flurbiprofen axetil in Post-extubation sore throat (POST), dysphonia and postoperative nausea and vomiting (PONV) (4 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: post-operative sore throat and hoarseness. Started Mar 2021; status: recruiting.

02

Drugs

dexmedetomidineflurbiprofen axetil
03

Conditions

Post-extubation sore throat (POST)dysphoniapostoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on ChiCTR2100044376.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100044376.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call